NLRP3 overexpression was detected in reactive cholangiocytes in patients and murine models affected by primary sclerosing cholangitis; in vitro, NLRP3 activation stimulated the expression of IL-18 in cholangiocytes, with minimal effects on IL-1β [67]. This evidence concerns the gene NLRP3 and sclerosing cholangitis.